Unknown

Dataset Information

0

MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition.


ABSTRACT: Treatment of BRAF-mutant melanoma with combined dabrafenib and trametinib, which target RAF and the downstream MAP-ERK kinase (MEK)1 and MEK2 kinases, respectively, improves progression-free survival and response rates compared with dabrafenib monotherapy. Mechanisms of clinical resistance to combined RAF/MEK inhibition are unknown. We performed whole-exome sequencing (WES) and whole-transcriptome sequencing (RNA-seq) on pretreatment and drug-resistant tumors from five patients with acquired resistance to dabrafenib/trametinib. In three of these patients, we identified additional mitogen-activated protein kinase (MAPK) pathway alterations in the resistant tumor that were not detected in the pretreatment tumor, including a novel activating mutation in MEK2 (MEK2(Q60P)). MEK2(Q60P) conferred resistance to combined RAF/MEK inhibition in vitro, but remained sensitive to inhibition of the downstream kinase extracellular signal-regulated kinase (ERK). The continued MAPK signaling-based resistance identified in these patients suggests that alternative dosing of current agents, more potent RAF/MEK inhibitors, and/or inhibition of the downstream kinase ERK may be needed for durable control of BRAF-mutant melanoma.

SUBMITTER: Wagle N 

PROVIDER: S-EPMC3947296 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


Treatment of BRAF-mutant melanoma with combined dabrafenib and trametinib, which target RAF and the downstream MAP-ERK kinase (MEK)1 and MEK2 kinases, respectively, improves progression-free survival and response rates compared with dabrafenib monotherapy. Mechanisms of clinical resistance to combined RAF/MEK inhibition are unknown. We performed whole-exome sequencing (WES) and whole-transcriptome sequencing (RNA-seq) on pretreatment and drug-resistant tumors from five patients with acquired res  ...[more]

Similar Datasets

| S-EPMC8445818 | biostudies-literature
| S-EPMC3867020 | biostudies-literature
| S-EPMC8562134 | biostudies-literature
| S-EPMC3026446 | biostudies-literature
| S-EPMC4390490 | biostudies-literature
| S-EPMC3549295 | biostudies-literature
| S-EPMC4850735 | biostudies-literature
| S-EPMC4001781 | biostudies-literature
| S-EPMC4226803 | biostudies-literature
| S-EPMC4583389 | biostudies-literature